We are live on
!
Find out more
Pliant Therapeutics
PLRX
PLRX
91 hedge funds and large institutions have $62.5M invested in Pliant Therapeutics in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
9% more capital invested
Capital invested by funds: $57.5M → $62.5M (+$4.94M)
4.26% more ownership
Funds ownership: 75.98% → 80.24% (+4.3%)
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
5% less funds holding
Funds holding: 96 → 91 (-5)
63% less call options, than puts
Call options by funds: $89K | Put options by funds: $238K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
91
Holders Change
-5
Holders Change %
-5.21%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
26
Reduced
26
Closed
16
Calls
$89K
Puts
$238K
Net Calls
-$149K
Net Calls Change
-$133K
Top Buyers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$3.17M |
| 2 |
Two Sigma Investments
New York
|
+$1.64M |
| 3 |
Renaissance Technologies
New York
|
+$1.02M |
| 4 |
Millennium Management
New York
|
+$974K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$812K |
